Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

ZCWPW1 loss-of-function variants in Alzheimer’s Disease

View ORCID ProfileFahri Küçükali, Katrin Nußbaumer, Jasper Van Dongen, View ORCID ProfileElisabeth Hens, View ORCID ProfileCéline Bellenguez, Benjamin Grenier-Boley, View ORCID ProfileDelphine Daian, View ORCID ProfileAnne Boland, View ORCID ProfileJean-François Deleuze, View ORCID ProfileJean-Charles Lambert, View ORCID ProfileChristine Van Broeckhoven, View ORCID ProfileKristel Sleegers on behalf of the BELNEU Consortium
doi: https://doi.org/10.1101/2021.08.13.21261426
Fahri Küçükali
1Complex Genetics of Alzheimer’s Disease Group, Center for Molecular Neurology, VIB, Antwerp, Belgium
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fahri Küçükali
Katrin Nußbaumer
3University of Applied Sciences Campus Vienna, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jasper Van Dongen
1Complex Genetics of Alzheimer’s Disease Group, Center for Molecular Neurology, VIB, Antwerp, Belgium
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabeth Hens
4Neurodegenerative Brain Diseases Group, VIB Center for Molecular Neurology, Antwerp, Belgium
5Department of Neurology and Memory Clinic, Hospital Network Antwerp, Middelheim and Hoge Beuken, Antwerp, Belgium
6Department of Neurology, University Hospital Antwerp, Edegem, Belgium
7Department of Neurology, University Hospital Brussel and Center for Neurosciences, Free University of Brussels, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elisabeth Hens
Céline Bellenguez
8Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE facteurs de risque et déterminants moléculaires des maladies liés au vieillissement, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Céline Bellenguez
Benjamin Grenier-Boley
8Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE facteurs de risque et déterminants moléculaires des maladies liés au vieillissement, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Delphine Daian
9Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, 91057, Evry, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Delphine Daian
Anne Boland
9Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, 91057, Evry, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anne Boland
Jean-François Deleuze
9Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, 91057, Evry, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jean-François Deleuze
Jean-Charles Lambert
8Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE facteurs de risque et déterminants moléculaires des maladies liés au vieillissement, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jean-Charles Lambert
Christine Van Broeckhoven
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
4Neurodegenerative Brain Diseases Group, VIB Center for Molecular Neurology, Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christine Van Broeckhoven
Kristel Sleegers
1Complex Genetics of Alzheimer’s Disease Group, Center for Molecular Neurology, VIB, Antwerp, Belgium
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kristel Sleegers
  • For correspondence: kristel.sleegers{at}uantwerpen.vib.be
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Genome-wide association studies (GWAS) have identified more than 75 genetic risk loci for Alzheimer’s Disease (AD), however for a substantial portion of these loci the genetic variants or genes directly involved in AD risk remain to be found. A GWAS locus defined by the index SNP rs1476679 in ZCWPW1 is one of the largest AD loci as the association signal spans 56 potential risk genes. The three most compelling candidate genes in this locus are ZCWPW1, PILRA and PILRB, based on genetic, transcriptomic, and proteomic evidence. We performed amplicon-based target enrichment and next-generation sequencing of the exons, exon-intron boundaries, and UTRs of ZCWPW1, PILRA and PILRB on an Illumina MiSeq platform in 1048 Flanders-Belgian late-onset AD patients and 1037 matched healthy controls. Along with the single-marker association testing, the combined effect of Sanger-validated rare variants was evaluated in SKAT-O. No common variants (n = 40) were associated with AD. We identified 20 validated deleterious rare variants (MAF < 1%, CADD score ≥ 20), 14 of which in ZCWPW1. This included 4 predicted loss-of-function (LoF) mutations that were exclusively found in patients (P = 0.011). Haplotype sharing analysis revealed distant common ancestors for two LoF mutations. Single-molecule long-read Nanopore sequencing analysis unveiled that all LoF mutations are phased with the risk haplotype in the locus. Our results support the recent report for the role of ultra-rare LoF ZCWPW1 variants in AD and suggest a potential risk mechanism for AD through ZCWPW1 haploinsufficiency.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The research was funded in part by the Alzheimer Research Foundation (SAO-FRA), the Research Foundation Flanders (FWO), and the University of Antwerp Research Fund, Belgium. FK is a supported by a PhD fellowship from the University of Antwerp Research Fund. This work was supported in part by a grant (European Alzheimer DNA BioBank, EADB) from the EU Joint Programme - Neurodegenerative Disease Research (JPND). Inserm UMR1167 is also funded by Inserm, Institut Pasteur de Lille, the Lille Métropole Communauté Urbaine, the French government's LABEX DISTALZ program (development of innovative strategies for a transdisciplinary approach to Alzheimer's disease).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All participants and/or their legal guardian signed written informed consent forms before inclusion. The study protocols were approved by the ethics committees of the Antwerp University Hospital and the University of Antwerp, and the ethics committees of the participating neurological centers of the BELNEU consortium.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵$ The following members of the BELNEU Consortium have contributed to the clinical and pathological phenotyping and follow-up of the Belgian patient cohorts: Johan Goeman, Roeland Crols (Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium); Dirk Nuytten (Hospital Network Antwerp (ZNA) Stuivenberg, Antwerp, Belgium); Rudy Mercelis (Antwerp University Hospital, Edegem); Mathieu Vandenbulcke (University of Leuven and University Hospitals Leuven, Leuven, Belgium); Anne Sieben, Jan L. De Bleecker, Patrick Santens (University Hospital Ghent, Ghent, Belgium); Jan Versijpt, Alex Michotte (University Hospital Brussels, Brussels, Belgium); Olivier Deryck, Ludo Vanopdenbosch, Bruno Bergmans (AZ Sint-Jan Brugge, Bruges, Belgium); Christiana Willems, Nina De Klippel (Jessa Hospital, Hasselt, Belgium); Jean Delbeck (General Hospital Sint-Maria, Halle); Adrian Ivanoiu (Saint-Luc University Hospital, Université Catholique de Louvain, Louvain-la-Neuve, Belgium); and Eric Salmon (University of Liege and Memory Clinic, CHU Liege, Liege, Belgium).

Data Availability

To comply with EU law and participant privacy, individual-level clinical and genetic data cannot be shared publicly, however summary statistics for single marker genetic association and gene-based rare variant association analyses can be found in the manuscript and the supplementary tables.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted August 13, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
ZCWPW1 loss-of-function variants in Alzheimer’s Disease
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
ZCWPW1 loss-of-function variants in Alzheimer’s Disease
Fahri Küçükali, Katrin Nußbaumer, Jasper Van Dongen, Elisabeth Hens, Céline Bellenguez, Benjamin Grenier-Boley, Delphine Daian, Anne Boland, Jean-François Deleuze, Jean-Charles Lambert, Christine Van Broeckhoven, Kristel Sleegers
medRxiv 2021.08.13.21261426; doi: https://doi.org/10.1101/2021.08.13.21261426
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
ZCWPW1 loss-of-function variants in Alzheimer’s Disease
Fahri Küçükali, Katrin Nußbaumer, Jasper Van Dongen, Elisabeth Hens, Céline Bellenguez, Benjamin Grenier-Boley, Delphine Daian, Anne Boland, Jean-François Deleuze, Jean-Charles Lambert, Christine Van Broeckhoven, Kristel Sleegers
medRxiv 2021.08.13.21261426; doi: https://doi.org/10.1101/2021.08.13.21261426

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (428)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3286)
  • Dentistry and Oral Medicine (362)
  • Dermatology (276)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1168)
  • Epidemiology (13349)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5140)
  • Geriatric Medicine (480)
  • Health Economics (781)
  • Health Informatics (3260)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1189)
  • Hematology (429)
  • HIV/AIDS (1015)
  • Infectious Diseases (except HIV/AIDS) (14618)
  • Intensive Care and Critical Care Medicine (912)
  • Medical Education (476)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4914)
  • Nursing (262)
  • Nutrition (725)
  • Obstetrics and Gynecology (880)
  • Occupational and Environmental Health (795)
  • Oncology (2517)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (542)
  • Pediatrics (1299)
  • Pharmacology and Therapeutics (549)
  • Primary Care Research (555)
  • Psychiatry and Clinical Psychology (4198)
  • Public and Global Health (7489)
  • Radiology and Imaging (1703)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (479)
  • Sexual and Reproductive Health (496)
  • Sports Medicine (424)
  • Surgery (547)
  • Toxicology (72)
  • Transplantation (235)
  • Urology (204)